Iranian Journal of Public Health 2017. 46(8):1104-1109.

Evaluation of the Level of Zinc and Malondialdehyde in Basal Cell Carcinoma
Ziba MAJIDI, Mahmoud DJALALI, Mohammad Hasan JAVANBAKHT, Mojtaba FATHI, Mahnaz ZAREI, Koorosh FOLADSAZ

Abstract


Abstract

Background: Basal Cell Carcinoma (BCC) is one of the most common skin cancers in the world and that use to lifestyle, increasing chemical pollutions, environmental factors and poor nutrition. The most important cause of this cancer is oxidative stress and free radicals so antioxidant activities for the body are so important. The aim of this study was to determine the variation of zinc and (Malondialdehyde) MDA in BCC patients.

Methods: This study has been performed on case and control patients from 2013 to 2014. The samples were collected from cell carcinoma patients at Razi Hospital in Tehran, Iran. We evaluated the level of zinc with the use of Atomic Absorption Spectroscopy (AAS) method. Besides, we evaluated MDA with colorimetric assay.

Results: The concentration of MDA was significantly higher in case group in comparison to control group (P=0.001). In addition, case group had lower concentration of zinc than the control group (P=0.000). There was no correlation between MDA and body mass index (BMI) and between zinc and BMI.

Conclusion: All the patients with BCC showed a significant MDA serum in comparison with control group. However, significant decrease in zinc serum of the patients was seen that is because of consuming zinc during oxidative stress process so topical use of zinc in the form of 2+ ions could be effective on antioxidant protection against the sun UV radiation.

 

 


Keywords


Basal cell carcinoma; Zinc; Malondialdehyde; Skin cancer

Full Text:

PDF

References


Arredondo-García JL, Soriano-Becerril D, Solórzano-Santos F, et al (2007). Resistance of uropathogenic bacteria to first-line antibiotics in Mexico City: a multicenter susceptibility analysis. Curr Ther Res Clin Exp, 68 (2): 120-26.

Marzuka A,Book S(2015). Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med, 88 (2): 167-79.

McCusker M, Basset-Seguin N, Dummer R, et al (2014). Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer , 50 (4): 774-83.

Gorlin RJ(2004). Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med, 6 530-9.

Lo Muzio L, Nocini PF, Savoia A, et al (1999). Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals. Clin Genet, 55 (1): 34-40.

Moan J, Grigalavicius M, Baturaite Z, Dahlback A, and Juzeniene A (2015). The relationship between UV exposure and incidence of skin cancer. Photodermatol Photoimmunol Photomed, 31 (1): 26-35.

Cabrera HN, Gómez ML(2003). Skin cancer induced by arsenic in the water. J Cutan Med Surg, 7 (2): 106-11.

Dourmishev LA, Rusinova D, and Botev I (2013). Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol Online J, 4 (1): 12-17.

Chan PC, Haseman JK, Boorman GA, et al (1986). Forestomach lesions in rats and mice administered 3-chloro-2-methylpropene by gavage for two years. Cancer Res, 46(12 Pt 1): 6349-52.

Epstein EH (2008). Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer, 8(10): 743-54.

Shalaby SI, Mohammad E-B, Shalaby SIA, et al (2014). Detection of Coproantigens by Sandwich ELISA in Rabbits Experimentally Infected with Fasciola gigantica. Iran J Parasitol, 9 (3): 374-81.

Berking C, Hauschild A, Kölbl O, et al (2014). Basal cell carcinoma-treatments for the commonest skin cancer. Dtsch Arztebl Int, 111 (22): 389-95.

Phaniendra A, Jestadi DB, and Periyasamy L(2015). Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem, 30 (1): 11-26.

Godic A, Poljšak B, Adamic M, and Dahmane R (2014). The role of antioxidants in skin cancer prevention and treatment. Oxid Med Cell Longev, 2014: 860479.

Afanas’ev I(2014). Reactive oxygen species signaling in cancer: comparison with aging. Aging Dis, 2 (3): 219-30.

Schieber M, Chandel NS (2014). ROS function in redox signaling and oxidative stress. Curr Biol, 24 (10): R453-62.

Subapriya R, Kumaraguruparan R, Nagini S, Thangavelu A(2003). Oxidant-antioxidant status in oral precancer and oral cancer patients. Toxicol Mech Methods, 13 (1): 77-81.

Manoharan S, Kolanjiappan K, Suresh K, Panjamurthy K(2005). Lipid peroxidation & antioxidants status in patients with oral squamous cell carcinoma. Indian J Med Res, 122 (6): 529-34.

Rahmani H, Korani M, Sarasgani MR, et al (2013). Peroxidative Activity in Patients with Skin Basal Cell Carcinoma. J Cancer Ther, 4 (6A):38-42.

Williams J, Jacobson EL, Kim H, et al (2012). Folate in skin cancer prevention. Subcell Biochem, 56: 181-97.

D'souza D, Babu GS, Shetty SR, Balan P (2012). Estimation of serum malondialdehyde in potentially malignant disorders and post-antioxidant treated patients: A biochemical study. Contemp Clin Dent, 3 (4): 448-51.

Ramya R, Prakash S, and Sudha S(2011). Assessment of Serum Malondialdehyde in Oral Squamous Cell Carcinoma patients and its association with tobacco habits. J Pharm Biomed Sci, 10 (16):1-3.

McCord MC, Aizenman E(2014). The role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease. Front Aging Neurosci, 6:77.

Powell SR(2000). The antioxidant properties of zinc. J Nutr, 130(5S Suppl):1447S-54S.

Prasad AS(2014). Zinc: an antioxidant and anti-inflammatory agent: role of zinc in degenerative disorders of aging. J Trace Elem Med Biol 28 (4): 364-71.

Bibi NY, Cohen A(2006). Zinc in skin pathology and care. J Dermatolog Treat, 17 (4): 205-10.

Sharquie KE, Al-Nuaimy AA, Al-Shimary FA(2005). New intralesional therapy for basal cell carcinoma by 2% zinc sulphate solution. Saudi Med J, 26 (2): 359-61.

Christudoss P, Selvakumar R, Fleming JJ, Gopalakrishnan G(2011). Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma. Indian J Urol, 27 (1): 14-8.

Goyal M, Kalwar A, Vyas R, Bhati A(2006). A study of serum zinc, selenium and copper levels in carcinoma of esophagus patients. Indian J Clin Biochem, 21 (1): 208-10.

Heidari M, Najafi F(2013). Trends of skin cancer incidence in 6 geographical regions of the Islamic Republic of Iran, 2000-2005. East Mediterr Health J, 19 (1): 59-65.

Fallah M. Cancer Incidence in Five Provinces of Iran: Ardebil, Gilan, Mazandaran, Golestan and Kerman, 1996-2000 (PhD thesis). Tampere School of Public Health, University of Tampere, Finland,2007.

Prasad AS, Bao B, Beck FW, et al (2004). Antioxidant effect of zinc in humans. Free Radic Biol Med, 37 (8): 1182-90.

Vural P, Canbaz M, Selçuki D(1999). Plasma antioxidant defense in actinic keratosis and basal cell carcinoma. J Eur Acad Dermatol Venereol, 13 (2): 96-101.

Rostan EF, DeBuys HV, Madey DL, Pinnell SR(2002). Evidence supporting zinc as an important antioxidant for skin. Int J Dermatol, 41 (9): 606-11.

Richard M-j, Favier A, B’Eani J-C(1999). Zinc protects against ultraviolet A1-induced DNA damage and apoptosis in cultured human fibroblasts. Biol Trace Elem Res,69 (3): 177-90.

Inutsuka S, Araki S(1978). Plasma copper and zinc levels in patients with malignant tumors of digestive organs. Clinical evaluation of the Cu/Zn ratio. Cancer, 42 (2): 626-31.

Sander C, Hamm F, Elsner P, Thiele J(2003). Oxidative stress in malignant melanoma and non‐melanoma skin cancer. Br J Dermatol, 148 (5): 913-22.

Sander CS, Chang H, Salzmann S, et al (2002). Photoaging is associated with protein oxidation in human skin in vivo. J Invest Dermatol, 118 (4): 618-25.

Staibano S, Lo Muzio L, Pannone G, et al (2001). P53 and hMSH2 expression in basal cell carcinomas and malignant melanomas from photoexposed areas of head and neck region. Int J Oncol, 19 (3): 551-59.

Del Rio D, Stewart AJ, Pellegrini N(2005). A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis, 15 (4): 316-28.

Pilz J, Meineke I, and Gleiter CH(2000). Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2, 4-dinitrophenylhydrazine derivative. J Chromatogr B Biomed Sci Appl, 742 (2): 315-25.

Suttnar J, Čermák J, Dyr JE (1997). Solid-phase extraction in malondialdehyde analysis. Anal Biochem, 249 (1): 20-23.

Mášová L, Dyr JE(2001). Influence of citrate and EDTA anticoagulants on plasma malondialdehyde concentrations estimated by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl, 751 (1): 193-7.

Guertin F, Brunet S, Gavino V, et al (1994). Malondialdehyde-modified high-density lipoprotein cholesterol: plasma removal, tissue distribution and biliary sterol secretion in rats. Biochim Biophys Acta, 1214 (2): 137-42.

Esterbauer H, Schaur RJr, Zollner H (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med, 11 (1): 81-128.

Marnett L (1999). Chemistry and biology of DNA damage by malondialdehyde. IARC Sci Publ, (150): 17-27.

Thiele JJ, Traber MG, Polefka TG, et al (1997). Ozone-exposure depletes vitamin E and induces lipid peroxidation in murine stratum corneum. J Invest Dermatol, 108 (5): 753-57.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.